These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2. Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365 [TBL] [Abstract][Full Text] [Related]
5. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Husain D; Miller JW; Michaud N; Connolly E; Flotte TJ; Gragoudas ES Arch Ophthalmol; 1996 Aug; 114(8):978-85. PubMed ID: 8694734 [TBL] [Abstract][Full Text] [Related]
6. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Augustin AJ; Schmidt-Erfurth U Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209 [TBL] [Abstract][Full Text] [Related]
7. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Kramer M; Miller JW; Michaud N; Moulton RS; Hasan T; Flotte TJ; Gragoudas ES Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419 [TBL] [Abstract][Full Text] [Related]
8. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients]. Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900 [TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Miller JW; Walsh AW; Kramer M; Hasan T; Michaud N; Flotte TJ; Haimovici R; Gragoudas ES Arch Ophthalmol; 1995 Jun; 113(6):810-8. PubMed ID: 7540388 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with verteporfin: a new treatment in ophthalmology. Michels S; Schmidt-Erfurth U Semin Ophthalmol; 2001 Dec; 16(4):201-6. PubMed ID: 15513441 [TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Bressler NM; Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980 [TBL] [Abstract][Full Text] [Related]
12. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC; Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216 [TBL] [Abstract][Full Text] [Related]
13. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration. Hariprasad SM; Shah GK Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487 [TBL] [Abstract][Full Text] [Related]
14. Duration of skin photosensitivity and incidence of photosensitivity reactions after administration of verteporfin. Houle JM; Strong HA Retina; 2002 Dec; 22(6):691-7. PubMed ID: 12476093 [TBL] [Abstract][Full Text] [Related]
18. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin. Schmidt-Erfurth UM; Michels S Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383 [TBL] [Abstract][Full Text] [Related]
19. Combining photodynamic therapy and feeder vessel photocoagulation: a pilot study. Staurenghi G; Massacesi A; Musicco I; Salvetti P; Viola F Semin Ophthalmol; 2001 Dec; 16(4):233-6. PubMed ID: 15513446 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of verteporfin pharmakokinetics--redefining the need of photosensitizers in ophthalmology. Ziemssen F; Heimann H Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):1023-41. PubMed ID: 22762303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]